The acute ischemic stroke market is expected to rise owing to the growing prevalence and awareness of the disease over the forecast period. In addition, the launch of various multi-stage acute ischemic stroke pipeline products will significantly revolutionize the dynamics of the acute ischemic stroke market.
by DelveInsight “Acute Ischemic Stroke Market Overview, Epidemiology and Market Forecast-2032” The report offers an in-depth understanding of Acute Ischemic Stroke, historical and forecasted epidemiology as well as Acute Ischemic Stroke market trends in the United States, EU5 (Germany, Spain, Italy, France and UK) and Japan.
Overview of Acute Ischemic Stroke
Acute ischemic stroke (AIS) occurs when blood flow in a cerebral artery is blocked by a mass of thickened blood. Clots are either thrombotic or embolic, depending on where they develop in the body. A thrombotic stroke, the more common of the two, occurs when a clot forms in an artery in the brain. An embolic stroke occurs when a clot or small piece of plaque (fatty deposit) breaks off from another part of the body, such as the heart, and travels through the bloodstream to get stuck in a narrower vessel of the brain.
Some of the key facts from the Acute Ischemic Stroke Market report:
- Acute Ischemic Stroke Market Size Expected to Grow with Significant Growth CAGR during the study period (2019-2032)
- According to the study conducted by Edward C Jauch and. Al.Almost 800,000 people suffer from strokes every year in the United States and 82–92% of these strokes are ischemic. Stroke is the fifth leading cause of death and disability in adults
- According to World Health Organization (WHO), about 15 million people around the world suffer a stroke every year. Among these, 5000000 die, and another 5000000 are left permanently disabled
- Major Acute Ischemic Stroke Companies: Athersy, Healios KK, Bristol-Myers Squibb, Lumosa Therapeutics, Abbie and others
- Main therapies for acute ischemic stroke: MultiStem, BMS986177, LT-3001, Elezanumab and others
- Gender-based epidemiology of acute ischemic stroke analyzed that men are at greater risk of acute ischemic stroke than women
Get Free Sample For Acute Ischemic Stroke Market Report
Key Highlights of Acute Ischemic Stroke Market Report:
- The Acute Ischemic Stroke Market report covers a descriptive overview and comprehensive overview of the acute ischemic stroke epidemiology and acute ischemic stroke market in 7MM (US, EU5 (Germany, Spain, France, Italy, UK) and Japan.)
- The Acute Ischemic Stroke Market report provides information on current and emerging therapies.
- The Acute Ischemic Stroke Market report provides historical and forecast global market covering the spread of drugs in 7MM.
- The Acute Ischemic Stroke Market report offers an advantage which will help in developing business strategies by understanding the trends shaping and driving the Acute Ischemic Stroke market.
Learn more about Therapies to Capture Major Acute Ischemic Stroke Market Share @ Acute Ischemic Stroke Market Forecast
Segmentation of acute ischemic stroke epidemiology:
The Acute Ischemic Stroke Market report offers epidemiological analysis for the study period 2019-2032 in 7MM segmented into:
- Total prevalence of acute ischemic strokes
- Prevalent cases of acute ischemic stroke by severity
- Sex-specific prevalence of acute ischemic stroke
- Diagnosed cases of acute episodic and chronic ischemic stroke
Acute Ischemic Stroke Market
The dynamics of the acute ischemic stroke market are expected to change in the coming years due to the anticipated launch of emerging therapies such as LT-3001, BMS-986177, Elezanumab, and others during the forecast period 2019-2032.
Download the report to understand what factors drive epidemiological trends in acute ischemic stroke @ Acute Ischemic Stroke Epidemiological Insights
Acute Ischemic Stroke Therapies and Key Companies
- Multi-stem: Athersys/Healios KK
- BMS986177: Bristol Myers Squibb
- LT-3001: Therapeutic Lumosa
- Elezanumab: Abby
Scope of the Acute Ischemic Stroke Market Report
- Study period: 2019-2032
- Cover: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
- Major Acute Ischemic Stroke Companies: Athersy, Healios KK, Bristol-Myers Squibb, Lumosa Therapeutics, Abbie and others
- Main therapies for acute ischemic stroke: MultiStem, BMS986177, LT-3001, Elezanumab and others
- Therapeutic assessment of acute ischemic stroke: Currently Marketed Treatments for Acute Ischemic Stroke and Emerging Therapies for Acute Ischemic Stroke
- Acute Ischemic Stroke Market Dynamics: Acute Ischemic Stroke Market Drivers and Acute Ischemic Stroke Market Barriers
- Competitive intelligence analysis: SWOT analysis, PESTLE analysis, Porter’s five forces, BCG matrix, market entry strategies
- Unmet Needs in Acute Ischemic Stroke, KOL Views, Analyst Views, Market Access and Reimbursement for Acute Ischemic Stroke
Contents
1. Introduction of Acute Ischemic Stroke Market Report
2. Executive Summary for Acute Ischemic Stroke
3. SWOT Analysis of Acute Ischemic Stroke
4. Share of Acute Ischemic Stroke Patients (%) At a Glance
5. Acute Ischemic Stroke Market Overview at a Glance
6. Background and overview of acute ischemic stroke
7. Epidemiology of acute ischemic stroke and patient population
8. Acute Ischemic Stroke Patient Population by Countries
9. Current treatment of acute ischemic stroke and medical practices
10. Unmet Needs in Acute Ischemic Stroke
11. Emerging therapies for acute ischemic stroke
12. Acute Ischemic Stroke Market Outlook
13. Acute Ischemic Stroke Market Analysis by Countries (2019-2032)
14. Access to the acute ischemic stroke market and reimbursement of therapies
15. Acute Ischemic Stroke Market Drivers
16. Acute Ischemic Stroke Market Barriers
17. Appendix Acute Ischemic Stroke
18. Acute Ischemic Stroke Reporting Methodology
19. DelveInsight Abilities
20. Disclaimer
21. About DelveInsight
To learn more about treating acute ischemic stroke, visit @ Medications for Acute Ischemic Stroke
Media Contact
Company Name: DelveInsight Business Research LLP
Contact person: Gaurav Bora
E-mail: Send an email
Call: 9193216187
Address:304 S. Jones Boulevard #2432
Town: Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/